{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:00:33Z","timestamp":1770771633191,"version":"3.50.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalradiologyonline.net","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.crad.2025.106849","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:25:34Z","timestamp":1739463934000},"page":"106849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical outcomes, toxic effect, and immune microenvironment changes of drug-eluting bead\u00a0bronchial arterial chemoembolisation\/bronchial arterial chemoembolization combined with immunotherapy in treating elderly patients with non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"84","author":[{"given":"J.","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3081-1722","authenticated-orcid":false,"given":"W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2025.106849_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.crad.2025.106849_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40425-018-0382-2","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)","volume":"6","author":"Brahmer","year":"2018","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.crad.2025.106849_bib3","doi-asserted-by":"crossref","first-page":"208-e417","DOI":"10.1634\/theoncologist.2019-0717","article-title":"Phase II study on Biweekly combination therapy of gemcitabine plus carboplatin for the treatment of elderly patients with advanced non-small cell lung cancer","volume":"25","author":"Takayama","year":"2020","journal-title":"The Oncologist"},{"key":"10.1016\/j.crad.2025.106849_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40266-017-0479-1","article-title":"Cancer immunotherapies: are they as effective in the elderly?","volume":"34","author":"Poropatich","year":"2017","journal-title":"Drugs & Aging"},{"key":"10.1016\/j.crad.2025.106849_bib5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/1759-7714.13522","article-title":"Clinical effect of bronchial arterial infusion chemotherapy and CalliSpheres drug-eluting beads in patients with stage II-IV lung cancer: a prospective cohort study","volume":"11","author":"Shang","year":"2020","journal-title":"Thoracic Cancer"},{"key":"10.1016\/j.crad.2025.106849_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0284185121994298","article-title":"Pirarubicin-loaded CalliSpheres\u00ae drug-eluting beads for the treatment of patients with stage III-IV lung cancer","volume":"63","author":"Bi","year":"2022","journal-title":"Acta Radiologica (Stockholm, Sweden : 1987)"},{"key":"10.1016\/j.crad.2025.106849_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1079707","article-title":"The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer","volume":"13","author":"Bi","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.crad.2025.106849_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/cbr.2020.3954","article-title":"Efficacy and safety of drug-eluting beads bronchial arterial chemoembolization in treating patients with lung cancer who were complicated with hemoptysis","volume":"38","author":"Fu","year":"2023","journal-title":"Cancer Biotherapy & Radiopharmaceuticals"},{"key":"10.1016\/j.crad.2025.106849_bib9","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/1759-7714.13139","article-title":"The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer","volume":"10","author":"Bie","year":"2019","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.crad.2025.106849_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7326\/0003-4819-159-6-201309170-00690","article-title":"Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation","volume":"159","author":"Humphrey","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.crad.2025.106849_bib11","first-page":"1031","article-title":"Comparison of clinicopathological and molecular features between young and old patients with lung cancer","volume":"11","author":"Zhong","year":"2018","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/j.crad.2025.106849_bib12","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1001\/jamaoncol.2021.4960","article-title":"Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 Years or older with cancer: a multicenter international cohort study","volume":"7","author":"Nebhan","year":"2021","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.crad.2025.106849_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7376844","article-title":"Analysis on the efficacy of bronchial artery chemoembolization combined with 125I seed implantation in the therapy of advanced non-small-cell lung cancer based on the medical database","volume":"2022","author":"Xie","year":"2022","journal-title":"BioMed Research International"},{"key":"10.1016\/j.crad.2025.106849_bib14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cllc.2021.12.011","article-title":"Clinical effectiveness and safety of anti-PD-(L)1 therapy among older adults with advanced non-small cell lung cancer","volume":"23","author":"Altan","year":"2022","journal-title":"Clinical Lung Cancer"},{"key":"10.1016\/j.crad.2025.106849_bib15","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jvir.2021.08.019","article-title":"Sintilimab plus bronchial arterial infusion chemotherapy\/drug-eluting embolic chemoembolization for advanced non-small cell lung cancer: a Preliminary study of 10 patients","volume":"32","author":"Li","year":"2021","journal-title":"Journal of Vascular and Interventional Radiology : JVIR"},{"key":"10.1016\/j.crad.2025.106849_bib16","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.21037\/qims-23-287","article-title":"Drug-eluting beads bronchial arterial chemoembolization\/bronchial arterial infusion chemotherapy with and without PD-1 blockade for advanced non-small cell lung cancer: a comparative single-center cohort study","volume":"13","author":"Xu","year":"2023","journal-title":"Quantitative Imaging in Medicine and Surgery"},{"key":"10.1016\/j.crad.2025.106849_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1201468","article-title":"Drug-eluting beads bronchial arterial chemoembolization vs. conventional bronchial arterial chemoembolization in the treatment of advanced non-small cell lung cancer","volume":"10","author":"Yu","year":"2023","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.crad.2025.106849_bib18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2217\/fon-2021-1261","article-title":"Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol","volume":"18","author":"Ben Khaled","year":"2022","journal-title":"Future Oncology (London, England)"},{"key":"10.1016\/j.crad.2025.106849_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.14218\/JCTH.2020.00001","article-title":"Management and treatment of hepatocellular carcinoma with immunotherapy: a review of current and future options","volume":"8","author":"Ghavimi","year":"2020","journal-title":"Journal of Clinical and Translational Hepatology"},{"key":"10.1016\/j.crad.2025.106849_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.992526","article-title":"Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: a case series study","volume":"13","author":"Bi","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.crad.2025.106849_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.crad.2025.106849_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22964","article-title":"Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab","volume":"33","author":"Liu","year":"2019","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"10.1016\/j.crad.2025.106849_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106677","article-title":"Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis","volume":"85","author":"Zhang","year":"2020","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.crad.2025.106849_bib24","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.3892\/ol.2016.4216","article-title":"Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer","volume":"11","author":"Zou","year":"2016","journal-title":"Oncology Letters"},{"key":"10.1016\/j.crad.2025.106849_bib25","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.2147\/CMAR.S310115","article-title":"Drug-eluting beads bronchial arterial chemoembolization in treating Relapsed\/refractory small cell lung cancer patients: results from a pilot study","volume":"13","author":"Lin","year":"2021","journal-title":"Cancer Management and Research"},{"key":"10.1016\/j.crad.2025.106849_bib26","article-title":"Drug-eluting bead bronchial arterial chemoembolization with and without microwave ablation for the treatment of advanced and standard treatment-refractory\/ineligible non-small cell lung cancer: a comparative study","volume":"12","author":"Xu","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.crad.2025.106849_bib27","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00262-022-03140-5","article-title":"Severe immune-related adverse events of immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials","volume":"71","author":"Gu","year":"2022","journal-title":"Cancer Immunology, Immunotherapy : CII"},{"key":"10.1016\/j.crad.2025.106849_bib28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1186\/s12885-023-11668-7","article-title":"A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma","volume":"23","author":"Shi","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.crad.2025.106849_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaoncol.2023.6277","article-title":"Immunotherapy or chemoimmunotherapy in older adults with advanced non-small cell lung cancer","volume":"10","author":"Tsukita","year":"2024","journal-title":"JAMA Oncology"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T16:56:03Z","timestamp":1744822563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926025000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"alternative-id":["S0009926025000546"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2025.106849","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes, toxic effect, and immune microenvironment changes of drug-eluting bead\u00a0bronchial arterial chemoembolisation\/bronchial arterial chemoembolization combined with immunotherapy in treating elderly patients with non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2025.106849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"106849"}}